The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke: Feasibility, Safety, and Efficacy in the First Year of Clinical Practice
Abstract
Background and Purpose —The feasibility, safety, and efficacy of intravenous tissue plasminogen activator (t-PA) for patients with acute ischemic stroke in clinical practice need to be assessed. Methods —We initiated a prospective open-label study at a university hospital and two community hospitals in Houston, Tex, immediately after the publication of the National Institute of Neurological Disorders and Stroke (NINDS) t-PA study. A total of 30 patients, age 32 to 90 years, were treated with 0.9 mg/kg of intravenous t-PA (maximum dose, 90 mg) within 3 hours of acute ischemic stroke between December 1995 and December 1996. Results —Six percent (6%) of all patients hospitalized with ischemic stroke received intravenous t-PA at the university hospital and 1.1% at the community hospitals. The rates of total, symptomatic, and fatal intracerebral hemorrhage were 10%, 7%, and 3%. Thirty-seven percent (37%) of patients recovered to fully independent function. The average time from stroke onset to emergency department arrival was 57 minutes; emergency department arrival to computed tomography scan 41 minutes; and computed tomography scan to administration of treatment 59 minutes. Conclusions —When treatment guidelines are carefully followed in an urban hospital setting, intravenous t-PA for acute ischemic stroke is feasible and shows safety and efficacy comparable to the results of the NINDS study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Adams, H. P., Bendixen, B. H., Kappelle, L. J., Biller, J., Love, B. B., Gordon, D. L., & Marsh, E. E. (1993) · Stroke · doi:10.1161/01.str.24.1.35 · Cited by 12,335
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Best Subsets Logistic Regression
Hosmer, D. W., Jovanovic, B., & Lemeshow, S. (1989) · Biometrics · doi:10.2307/2531779 · Cited by 1,176
Multicentre Acute Stroke Trial—Italy (MAST-I) Group (1995) · The Lancet · doi:10.1016/s0140-6736(95)92049-8 · Cited by 633
Thrombolytic Therapy with Streptokinase in Acute Ischemic Stroke
(1996) · New England Journal of Medicine · doi:10.1056/nejm199607183350301 · Cited by 570
Generalized Efficacy of t-PA for Acute Stroke: Subgroup Analysis of the NINDS t-PA Stroke Trial
The NINDS t-PA Stroke Study Group (1997) · Stroke · doi:10.1161/01.str.28.11.2119 · Cited by 559
Streptokinase for Acute Ischemic Stroke With Relationship to Time of Administration
Donnan, G. A. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540120039031 · Cited by 360
Donnan, G. A. (1996) · JAMA · doi:10.1001/jama.276.12.961 · Cited by 294
Cited by
Adams, H. P., del Zoppo, G., Alberts, M. J., Bhatt, D. L., Brass, L., Furlan, A., Grubb, R. L., Higashida, R. T., Jauch, E. C., Kidwell, C., et al. (2007) · Stroke · doi:10.1161/strokeaha.107.181486 · Cited by 2,475
Self-citationAdams, H. P., Adams, R. J., Brott, T., del Zoppo, G. J., Furlan, A., Goldstein, L. B., Grubb, R. L., Higashida, R., Kidwell, C., Kwiatkowski, T. G., et al. (2003) · Stroke · doi:10.1161/01.str.0000064841.47697.22 · Cited by 1,245
Clark, W. M., Wissman, S., Albers, G. W., Jhamandas, J. H., Madden, K. P., Hamilton, S., & for the ATLANTIS Study Investigators (1999) · JAMA · doi:10.1001/jama.282.21.2019 · Cited by 1,186
Adams, H. P., del Zoppo, G., Alberts, M. J., Bhatt, D. L., Brass, L., Furlan, A., Grubb, R. L., Higashida, R. T., Jauch, E. C., Kidwell, C., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.181486 · Cited by 904
Self-citationRecommendations for the Establishment of Primary Stroke Centers
Alberts, M. J. (2000) · JAMA · doi:10.1001/jama.283.23.3102 · Cited by 725
Albers, G. W., Bates, V. E., Clark, W. M., Bell, R., Verro, P., & Hamilton, S. A. (2000) · JAMA · doi:10.1001/jama.283.9.1145 · Cited by 700
Kidwell, C. S., Saver, J. L., Mattiello, J., Starkman, S., Vinuela, F., Duckwiler, G., Gobin, Y. P., Jahan, R., Vespa, P., Kalafut, M., et al. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4<462::aid-ana9>3.0.co;2-y · Cited by 692
Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: The Cleveland Area Experience
Katzan, I. L., Furlan, A. J., Lloyd, L. E., Frank, J. I., Harper, D. L., Hinchey, J. A., Hammel, J. P., Qu, A., & Sila, C. A. (2000) · JAMA · doi:10.1001/jama.283.9.1151 · Cited by 648
Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
Kwiatkowski, T. G., Libman, R. B., Frankel, M., Tilley, B. C., Morgenstern, L. B., Lu, M., Broderick, J. P., Lewandowski, C. A., Marler, J. R., Levine, S. R., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906103402302 · Cited by 647
Self-citationAntithrombotic and Thrombolytic Therapy for Ischemic Stroke
Albers, G. W., Easton, J. D., Sacco, R. L., & Teal, P. (1998) · Chest · doi:10.1378/chest.114.5_supplement.683s · Cited by 617
Reducing in-hospital delay to 20 minutes in stroke thrombolysis
Meretoja, A., Strbian, D., Mustanoja, S., Tatlisumak, T., Lindsberg, P. J., & Kaste, M. (2012) · Neurology · doi:10.1212/wnl.0b013e31825d6011 · Cited by 560
Hemorrhagic Transformation of Ischemic Brain Tissue: Asymptomatic or Symptomatic?
Berger, C., Fiorelli, M., Steiner, T., Schäbitz, W.-R., Bozzao, L., Bluhmki, E., Hacke, W., & von Kummer, R. (2001) · Stroke · doi:10.1161/01.str.32.6.1330 · Cited by 552
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
Albers, G. W., Amarenco, P., Easton, J. D., Sacco, R. L., & Teal, P. (2004) · Chest · doi:10.1378/chest.126.3_suppl.483s · Cited by 466
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
Lansberg, M. G., O'Donnell, M. J., Khatri, P., Lang, E. S., Nguyen-Huynh, M. N., Schwartz, N. E., Sonnenberg, F. A., Schulman, S., Vandvik, P. O., Spencer, F. A., et al. (2012) · Chest · doi:10.1378/chest.11-2302 · Cited by 455
Hill, M. D. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041561 · Cited by 452
Kidwell, C. S., Starkman, S., Eckstein, M., Weems, K., & Saver, J. L. (2000) · Stroke · doi:10.1161/01.str.31.1.71 · Cited by 426
“Telestroke”: The Application of Telemedicine for Stroke
Levine, S. R., & Gorman, M. (1999) · Stroke · doi:10.1161/01.str.30.2.464 · Cited by 419
The Paul Coverdell Prototype Registries Writing Group* (2005) · Stroke · doi:10.1161/01.str.0000165902.18021.5b · Cited by 407
Reliability and Validity of Estimating the NIH Stroke Scale Score from Medical Records
Kasner, S. E., Chalela, J. A., Luciano, J. M., Cucchiara, B. L., Raps, E. C., McGarvey, M. L., Conroy, M. B., & Localio, A. R. (1999) · Stroke · doi:10.1161/01.str.30.8.1534 · Cited by 405
Self-citationTreatment of Acute Ischemic Stroke
Brott, T., & Bogousslavsky, J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431007 · Cited by 398
Schwamm, L. H., Pancioli, A., Acker, J. E., Goldstein, L. B., Zorowitz, R. D., Shephard, T. J., Moyer, P., Gorman, M., Johnston, S. C., Duncan, P. W., et al. (2005) · Circulation · doi:10.1161/01.cir.0000154252.62394.1e · Cited by 395
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke
Fagan, S. C., Morgenstern, L. B., Petitta, A., Ward, R. E., Tilley, B. C., Marler, J. R., Levine, S. R., Broderick, J. P., Kwiatkowski, T. G., Frankel, M., et al. (1998) · Neurology · doi:10.1212/wnl.50.4.883 · Cited by 385
Self-citationDemchuk, A. M., Morgenstern, L. B., Krieger, D. W., Linda Chi, T., Hu, W., Wein, T. H., Hardy, R. J., Grotta, J. C., & Buchan, A. M. (1999) · Stroke · doi:10.1161/01.str.30.1.34 · Cited by 377
Self-citationCerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: The PROACT II trial
Kase, C. S., Furlan, A. J., Wechsler, L. R., Higashida, R. T., Rowley, H. A., Hart, R. G., Molinari, G. F., Frederick, L. S., Roberts, H. C., Gebel, J. M., et al. (2001) · Neurology · doi:10.1212/wnl.57.9.1603 · Cited by 332
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
Albers, G. W., Amarenco, P., Easton, J. D., Sacco, R. L., & Teal, P. (2008) · Chest · doi:10.1378/chest.08-0720 · Cited by 320
Morris, D. L., Rosamond, W., Madden, K., Schultz, C., & Hamilton, S. (2000) · Stroke · doi:10.1161/01.str.31.11.2585 · Cited by 316
Neuronal Protection in Stroke by an sLe x -Glycosylated Complement Inhibitory Protein
Huang, J., Kim, L. J., Mealey, R., Marsh, H. C., Zhang, Y., Tenner, A. J., Connolly, E. S., & Pinsky, D. J. (1999) · Science · doi:10.1126/science.285.5427.595 · Cited by 315
Task Force Members, Schwamm, L. H., Pancioli, A., Acker, J. E., Goldstein, L. B., Zorowitz, R. D., Shephard, T. J., Moyer, P., Gorman, M., Johnston, S. C., et al. (2005) · Stroke · doi:10.1161/01.str.0000158165.42884.4f · Cited by 313
Wardlaw, J. M., & Mielke, O. (2005) · Radiology · doi:10.1148/radiol.2352040262 · Cited by 308
A Comprehensive Review of Prehospital and In-Hospital Delay Times in Acute Stroke Care
Evenson, K. R., Foraker, R. E., Morris, D. L., & Rosamond, W. D. (2009) · International Journal of Stroke · doi:10.1111/j.1747-4949.2009.00276.x · Cited by 290
Prioritizing interventions to improve rates of thrombolysis for ischemic stroke
California Acute Stroke Pilot Registry (CASPR) Investigators (2005) · Neurology · doi:10.1212/01.wnl.0000151850.39648.51 · Cited by 274
Kleindorfer, D., Lindsell, C. J., Brass, L., Koroshetz, W., & Broderick, J. P. (2008) · Stroke · doi:10.1161/strokeaha.107.490375 · Cited by 274
Reed, S. D., Cramer, S. C., Blough, D. K., Meyer, K., & Jarvik, J. G. (2001) · Stroke · doi:10.1161/01.str.32.8.1832 · Cited by 255
Houston Paramedic and Emergency Stroke Treatment and Outcomes Study (HoPSTO)
Wojner-Alexandrov, A. W., Alexandrov, A. V., Rodriguez, D., Persse, D., & Grotta, J. C. (2005) · Stroke · doi:10.1161/01.str.0000170700.45340.39 · Cited by 252
Self-citationStroke Biomarkers: Progress and Challenges for Diagnosis, Prognosis, Differentiation, and Treatment
Saenger, A. K., & Christenson, R. H. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.133801 · Cited by 252
Huang, J., Agus, D. B., Winfree, C. J., Kiss, S., Mack, W. J., McTaggart, R. A., Choudhri, T. F., Kim, L. J., Mocco, J., Pinsky, D. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171325998 · Cited by 225
An Overview of Acute Stroke Therapy: Past, Present, and Future
Fisher, M., & Schaebitz, W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3196 · Cited by 112
Metadata
- Authors
- Chiu, D., Krieger, D., Villar-Cordova, C., Kasner, S. E., Morgenstern, L. B., Bratina, P. L., Yatsu, F. M., & Grotta, J. C.
- Venue
- Stroke
- Published
- 1998-01
- Volume
- 29
- Issue
- 1
- Pages
- 18-22
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2148750186
- Cited by
- 406
- References
- 13
- FWCI
- 26.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.